DK1766056T3 - Breast cancer diagnosis oligonucleotides - Google Patents

Breast cancer diagnosis oligonucleotides

Info

Publication number
DK1766056T3
DK1766056T3 DK05747218.5T DK05747218T DK1766056T3 DK 1766056 T3 DK1766056 T3 DK 1766056T3 DK 05747218 T DK05747218 T DK 05747218T DK 1766056 T3 DK1766056 T3 DK 1766056T3
Authority
DK
Denmark
Prior art keywords
oligonucleotides
breast cancer
cancer diagnosis
diagnosis
breast
Prior art date
Application number
DK05747218.5T
Other languages
Danish (da)
Inventor
Praveen Sharma
Anders Loenneborg
Original Assignee
Diagenic As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diagenic As filed Critical Diagenic As
Application granted granted Critical
Publication of DK1766056T3 publication Critical patent/DK1766056T3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK05747218.5T 2004-06-02 2005-06-02 Breast cancer diagnosis oligonucleotides DK1766056T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0412301.4A GB0412301D0 (en) 2004-06-02 2004-06-02 Product and method
PCT/GB2005/002180 WO2005118851A1 (en) 2004-06-02 2005-06-02 Oligonucleotides for cancer diagnosis

Publications (1)

Publication Number Publication Date
DK1766056T3 true DK1766056T3 (en) 2011-03-14

Family

ID=32696533

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05747218.5T DK1766056T3 (en) 2004-06-02 2005-06-02 Breast cancer diagnosis oligonucleotides

Country Status (17)

Country Link
US (2) US8105773B2 (en)
EP (1) EP1766056B1 (en)
JP (1) JP5060945B2 (en)
CN (1) CN101027410A (en)
AP (1) AP2006003862A0 (en)
AT (1) ATE493511T1 (en)
AU (1) AU2005250219B2 (en)
CA (1) CA2568889A1 (en)
DE (1) DE602005025633D1 (en)
DK (1) DK1766056T3 (en)
ES (1) ES2358910T3 (en)
GB (1) GB0412301D0 (en)
NO (1) NO20065939L (en)
NZ (1) NZ551797A (en)
SI (1) SI1766056T1 (en)
WO (1) WO2005118851A1 (en)
ZA (1) ZA200610644B (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006128082A2 (en) * 2005-05-26 2006-11-30 The Johns Hopkins University Biomarkers for breast cancer
JP2007275027A (en) * 2006-04-12 2007-10-25 Fujifilm Corp Method for diagnosing cancer using cancer-related deletion gene marker
JP5208477B2 (en) * 2007-10-12 2013-06-12 生化学工業株式会社 Carrier for gene subtraction and use thereof
WO2011063232A1 (en) * 2009-11-20 2011-05-26 University Of Louisville Research Foundation, Inc. Biomarkers of cancer
GB201000688D0 (en) * 2010-01-15 2010-03-03 Diagenic Asa Product and method
CN110444287B (en) * 2011-04-29 2024-02-06 癌症预防和治疗有限公司 Methods for identifying and diagnosing pulmonary diseases using a classification system and kits therefor
KR20140099874A (en) * 2011-11-02 2014-08-13 나노프리시젼 프로덕츠 인코포레이션 Castellated optical fiber cable retention structure
JP6486826B2 (en) 2012-10-01 2019-03-20 ミレニアム ファーマシューティカルズ， インコーポレイテッドＭｉｌｌｅｎｎｉｕｍ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． Biomarkers and methods for predicting response to inhibitors and uses thereof
EP2922971B1 (en) * 2012-11-20 2018-10-17 Lund, Tore Eiliv Gene expression profile in diagnostics
JP6498210B2 (en) 2013-12-29 2019-04-10 チュアラボ オンコロジー, インコーポレーテッドCurelab Oncology, Inc. Methods and compositions relating to P62 / SQSTM1 for the treatment and prevention of inflammation-related diseases
KR102523245B1 (en) * 2014-06-18 2023-04-20 도레이 카부시키가이샤 Esophageal cancer detection kit or device, and detection method
FR3029210A1 (en) 2014-11-27 2016-06-03 Centre Nat De La Rech Scient (Cnrs) METHOD OF PROGNOSIS OF HEMOPATHIES
US10140708B2 (en) * 2016-01-21 2018-11-27 Riverside Research Institute Method for gestational age estimation and embryonic mutant detection
GB201611738D0 (en) * 2016-07-05 2016-08-17 Cambridge Entpr Ltd Biomarkers for inflammatory bowel disease
WO2019036388A1 (en) * 2017-08-14 2019-02-21 Raytheon Company Subtraction algorithm for detection of tumors
CN109529018B (en) * 2019-01-10 2021-11-30 南方医科大学南方医院 Application of ATXN2L in preparation of drug for reversing oxaliplatin resistance of gastric cancer
CN109596611A (en) * 2019-01-21 2019-04-09 湖北紫荆生物技术有限公司 A kind of water body calcium content test agent and water body calcium content measurement method
US11475558B2 (en) 2019-11-13 2022-10-18 Raytheon Company Organ isolation in scan data
US11282209B2 (en) 2020-01-10 2022-03-22 Raytheon Company System and method for generating contours
US11562512B2 (en) 2020-12-09 2023-01-24 Raytheon Company System and method for generating and displaying contours
US11893745B2 (en) 2020-12-09 2024-02-06 Raytheon Company System and method for generating and displaying contours
CN113913436B (en) * 2021-11-18 2023-09-29 天津市肿瘤医院（天津医科大学肿瘤医院） Reverse transcription transposable gene L1-ATP8B1, application thereof as lung squamous carcinoma marker and medicine for treating lung squamous carcinoma
CN115976212B (en) * 2022-12-21 2024-06-11 四川大学华西医院 Probe library and kit for detecting bone tumor diagnosis related genes

Family Cites Families (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4981783A (en) 1986-04-16 1991-01-01 Montefiore Medical Center Method for detecting pathological conditions
US6040138A (en) 1995-09-15 2000-03-21 Affymetrix, Inc. Expression monitoring by hybridization to high density oligonucleotide arrays
US5871928A (en) 1989-06-07 1999-02-16 Fodor; Stephen P. A. Methods for nucleic acid analysis
US5800992A (en) 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
US5925525A (en) 1989-06-07 1999-07-20 Affymetrix, Inc. Method of identifying nucleotide differences
JP2802125B2 (en) 1989-06-23 1998-09-24 キヤノン株式会社 Nucleic acid detection method
US5474796A (en) 1991-09-04 1995-12-12 Protogene Laboratories, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface
DE69214243T2 (en) 1991-09-23 1997-02-06 Pfizer Methods for the detection of specific mRNA and DNA in cells
GB2260811B (en) 1991-10-23 1995-07-05 Yorkshire Cancer Research Camp Detection of malignant tumours
AU691469B2 (en) 1992-03-04 1998-05-21 Synaptic Pharmaceutical Corporation DNA encoding taurine and gaba transporters and uses thereof
US6114114A (en) 1992-07-17 2000-09-05 Incyte Pharmaceuticals, Inc. Comparative gene transcript analysis
US5633137A (en) 1992-12-01 1997-05-27 The University Of South Florida Method for measuring specific gene expression: transcriptional activity per gene dose
US5677125A (en) 1994-01-14 1997-10-14 Vanderbilt University Method of detection and diagnosis of pre-invasive cancer
US5830645A (en) 1994-12-09 1998-11-03 The Regents Of The University Of California Comparative fluorescence hybridization to nucleic acid arrays
US5545531A (en) 1995-06-07 1996-08-13 Affymax Technologies N.V. Methods for making a device for concurrently processing multiple biological chip assays
US6156502A (en) 1995-12-21 2000-12-05 Beattie; Kenneth Loren Arbitrary sequence oligonucleotide fingerprinting
AU2253397A (en) 1996-01-23 1997-08-20 Affymetrix, Inc. Nucleic acid analysis techniques
WO1997029212A1 (en) 1996-02-08 1997-08-14 Affymetrix, Inc. Chip-based speciation and phenotypic characterization of microorganisms
WO1998008083A1 (en) 1996-08-20 1998-02-26 Motorola Inc. Method and apparatus for detecting predetermined molecular structures in a sample
US6235474B1 (en) 1996-12-30 2001-05-22 The Johns Hopkins University Methods and kits for diagnosing and determination of the predisposition for diseases
US6190857B1 (en) 1997-03-24 2001-02-20 Urocor, Inc. Diagnosis of disease state using MRNA profiles in peripheral leukocytes
NO972006D0 (en) * 1997-04-30 1997-04-30 Forskningsparken I Aas As New method for diagnosis of diseases
US5994076A (en) 1997-05-21 1999-11-30 Clontech Laboratories, Inc. Methods of assaying differential expression
WO1999006831A2 (en) 1997-07-29 1999-02-11 Dorssers Lambert C J Breast cancer resistance genes, methods for their detection and uses thereof
US6607879B1 (en) 1998-02-09 2003-08-19 Incyte Corporation Compositions for the detection of blood cell and immunological response gene expression
US6174680B1 (en) * 1998-12-30 2001-01-16 Dana-Farber Cancer Institute, Inc. Method for identifying mismatch repair glycosylase reactive sites, compounds and uses thereof
CA2318789C (en) 1998-02-25 2011-05-10 The United States Of America As Represented By The Secretary Department Of Health And Human Services Cellular arrays for rapid molecular profiling
US6004755A (en) 1998-04-07 1999-12-21 Incyte Pharmaceuticals, Inc. Quantitative microarray hybridizaton assays
CN1313908A (en) 1998-08-21 2001-09-19 纳克斯科尔公司 Assays using crosslinkable immobilized nucleic acids
US20090233276A1 (en) * 1998-09-22 2009-09-17 Oncomedx, Inc. Method Enabling the Use of Extracellular Ribonucleic Acid (RNA) Extracted from Plasma or Serum to Detect, Monitor or Evaluate Cancer or Premalignant Conditions
US6593084B2 (en) 1998-10-13 2003-07-15 Robert E. Bird Carcinogen assay
WO2000022172A1 (en) 1998-10-13 2000-04-20 Clontech Laboratories, Inc. Nucleic acid arrays
JP5213202B2 (en) 1998-10-28 2013-06-19 バイシス・インコーポレーテツド Detection and use of cell arrays and markers of genetic disorders
WO2000026412A1 (en) 1998-11-02 2000-05-11 Kenneth Loren Beattie Nucleic acid analysis using sequence-targeted tandem hybridization
US20040241726A1 (en) 1999-01-06 2004-12-02 Chondrogene Limited Method for the detection of allergies related gene transcripts in blood
US20050042630A1 (en) 1999-01-06 2005-02-24 Chondrogene Limited Method for the detection of asthma related gene transcripts in blood
US20040248169A1 (en) 1999-01-06 2004-12-09 Chondrogene Limited Method for the detection of obesity related gene transcripts in blood
US20040265868A1 (en) 1999-01-06 2004-12-30 Chondrogene Limited Method for the detection of depression related gene transcripts in blood
US20050123938A1 (en) 1999-01-06 2005-06-09 Chondrogene Limited Method for the detection of osteoarthritis related gene transcripts in blood
WO2000040749A2 (en) 1999-01-06 2000-07-13 Genenews Inc. Method for the detection of gene transcripts in blood and uses thereof
US20040241728A1 (en) 1999-01-06 2004-12-02 Chondrogene Limited Method for the detection of lung disease related gene transcripts in blood
US20040265869A1 (en) 1999-01-06 2004-12-30 Chondrogene Limited Method for the detection of type II diabetes related gene transcripts in blood
US20050003394A1 (en) 1999-01-06 2005-01-06 Chondrogene Limited Method for the detection of rheumatoid arthritis related gene transcripts in blood
US20040248170A1 (en) 1999-01-06 2004-12-09 Chondrogene Limited Method for the detection of hyperlipidemia related gene transcripts in blood
US7473528B2 (en) 1999-01-06 2009-01-06 Genenews Inc. Method for the detection of Chagas disease related gene transcripts in blood
US20040241727A1 (en) 1999-01-06 2004-12-02 Chondrogene Limited Method for the detection of schizophrenia related gene transcripts in blood
DE19937187A1 (en) * 1999-08-06 2001-03-01 Qiagen Gmbh Automated protein purification in multiwell format through vacuum filtration
AU2001278076A1 (en) * 2000-07-26 2002-02-05 Applied Genomics, Inc. Bstp-5 proteins and related reagents and methods of use thereof
US7108969B1 (en) * 2000-09-08 2006-09-19 Affymetrix, Inc. Methods for detecting and diagnosing oral cancer
US6955876B2 (en) * 2000-11-01 2005-10-18 Kane Michael D Compositions and systems for identifying and comparing expressed genes (mRNAs) in eukaryotic organisms
WO2002059367A2 (en) 2000-11-30 2002-08-01 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Diagnostic microarray for inflammatory bowel disease, crohn's disease and ulcerative colitis
EP1350114A2 (en) * 2001-01-12 2003-10-08 Yale University Detection of survivin in the biological fluids of cancer patients
US20020132274A1 (en) * 2001-01-17 2002-09-19 Nevalainen Marja T. Diagnostic and monitorings methods for cancer
AU2002253878A1 (en) 2001-01-25 2002-08-06 Gene Logic, Inc. Gene expression profiles in breast tissue
AU2002237124B2 (en) 2001-02-28 2008-03-06 Chondrogene Inc. Compositions and methods relating to osteoarthritis
WO2002088750A2 (en) * 2001-05-02 2002-11-07 Oxford Glycosciences (Uk) Ltd Proteins, genes and their use for diagnosis and treatment of breast cancer
US20020169560A1 (en) 2001-05-12 2002-11-14 X-Mine Analysis mechanism for genetic data
US7335467B2 (en) * 2001-05-15 2008-02-26 Ludwig Institute For Cancer Research Breast cancer antigens
US20030036077A1 (en) * 2001-05-31 2003-02-20 Chronix Biomedical Methods for generating an mRNA expression profile from an ecellular mRNA containing blood sample and using the same to identify functional state markers
WO2003001985A2 (en) * 2001-06-28 2003-01-09 Dermtech International Method for detection of melanoma
WO2003008963A1 (en) * 2001-07-18 2003-01-30 University Of Louisville Research Foundation, Inc. E-genechip online web service for data mining bioinformatics
US7229774B2 (en) * 2001-08-02 2007-06-12 Regents Of The University Of Michigan Expression profile of prostate cancer
US7622260B2 (en) * 2001-09-05 2009-11-24 The Brigham And Women's Hospital, Inc. Diagnostic and prognostic tests
US7371736B2 (en) * 2001-11-07 2008-05-13 The Board Of Trustees Of The University Of Arkansas Gene expression profiling based identification of DKK1 as a potential therapeutic targets for controlling bone loss
US7668659B2 (en) * 2001-11-07 2010-02-23 The Board Of Trustees Of The University Of Arkansas Diagnosis and classification of multiple myeloma
US20030232350A1 (en) * 2001-11-13 2003-12-18 Eos Biotechnology, Inc. Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
WO2003041562A2 (en) * 2001-11-14 2003-05-22 Whitehead Institute For Biomedical Research Molecular cancer diagnosis using tumor gene expression signature
AU2002361908A1 (en) * 2001-12-31 2003-07-24 Quark Biotech, Inc. Methods for identifying marker genes for cancer
US20030195431A1 (en) * 2002-04-10 2003-10-16 Sukhatme Vikas P. Observation of effects of body fluids on indicator cells for disease diagnosis
WO2003100000A2 (en) * 2002-05-24 2003-12-04 Tularik Inc. Amplification and overexpression of oncogenes
CN100478689C (en) * 2002-08-30 2009-04-15 肿瘤疗法科学股份有限公司 Polypeptide and use thereof
EP1581652A4 (en) 2002-09-12 2008-02-13 Genenews Corp Identification of sequences particularly useful for the diagnosis and identification of therapeutic targets for osteoarthritis
US20060024692A1 (en) * 2002-09-30 2006-02-02 Oncotherapy Science, Inc. Method for diagnosing non-small cell lung cancers
GB0227238D0 (en) * 2002-11-21 2002-12-31 Diagenic As Product and method
US7910550B2 (en) * 2004-04-16 2011-03-22 Stc.Unm Human kunitz-type inhibitor with enhanced antifibrinolytic activity
EP1809765A2 (en) * 2004-11-04 2007-07-25 Roche Diagnostics GmbH Classification of acute myeloid leukemia
US20070178503A1 (en) * 2005-12-19 2007-08-02 Feng Jiang In-situ genomic DNA chip for detection of cancer

Also Published As

Publication number Publication date
NZ551797A (en) 2010-03-26
JP2008501332A (en) 2008-01-24
AU2005250219A1 (en) 2005-12-15
US20120295800A1 (en) 2012-11-22
AU2005250219B2 (en) 2011-01-20
ZA200610644B (en) 2008-07-30
SI1766056T1 (en) 2011-05-31
EP1766056B1 (en) 2010-12-29
ATE493511T1 (en) 2011-01-15
CA2568889A1 (en) 2005-12-15
US8105773B2 (en) 2012-01-31
DE602005025633D1 (en) 2011-02-10
JP5060945B2 (en) 2012-10-31
GB0412301D0 (en) 2004-07-07
US20080026385A1 (en) 2008-01-31
WO2005118851A1 (en) 2005-12-15
CN101027410A (en) 2007-08-29
AP2006003862A0 (en) 2006-12-31
EP1766056A1 (en) 2007-03-28
ES2358910T3 (en) 2011-05-16
NO20065939L (en) 2007-02-08

Similar Documents

Publication Publication Date Title
DK1766056T3 (en) Breast cancer diagnosis oligonucleotides
DE602006018953D1 (en) mammography
BRPI0814889A2 (en) alpha7-selective ligand treatment.
DK1954834T3 (en) breast Cancer Markers
DK2785150T3 (en) HAND-MADE X-ray device
DE602005026825D1 (en) ENDOSCOPE
PL1720611T3 (en) Diagnostic marker for cancer
ATE527355T1 (en) C-CLASS SEMI-SOFT IMMUNO-STIMULATIVE OLIGONUCLEOTIDES
HK1110244A1 (en) Breast pump set
EP1797903A4 (en) Diagnostic agent for tumor
FI20050836A (en) X-ray
DE602006013094D1 (en) CANCER AGENT
NL1029919A1 (en) Therapeutic diphenyl ether ligands.
ITMI20042079A1 (en) DIAGNOSIS DEVICE
DE602005020905D1 (en) X-RAY UNIT
PL1858929T3 (en) Diagnosis of prostate cancer
IL179715A0 (en) Diagnosing or predicting the course of breast cancer
BRPI0813364A2 (en) DIAGNOSTIC METHODS AND CANCER TREATMENT.
DK1907574T3 (en) oligonucleotides
EP1846061A4 (en) Breast pump
DE602005026124D1 (en) ENDOSCOPE
NL1028326A1 (en) Imaging tomography device.
BRPI0807861A2 (en) CANCER DISEASE MODIFICATION ANTIBODY
DOP2005000176A (en) DIFENIL ETER THERAPEUTIC LIGANDS
SE0400897D0 (en) Appropriate treatment selection for breast cancer patients